Understanding Pituitary Macroadenomas

Pituitary macroadenomas are benign (non-cancerous) tumors on the pituitary gland. These are specifically 1 cm or larger in size. They can cause symptoms by compressing nearby structures (e.g. optic nerves) or affecting hormone levels depending on whether the tumor is functioning (producing hormones) or non-functioning (is not producing hormones). Most pituitary macroadenomas are slow-growing but due to their size and location at the base of the skull, they frequently require attention and careful evaluation. Surgical removal may be required.

Symptoms of Pituitary Macroadenoma

Symptoms depend on factors such as tumor size, growth direction, and whether it produces excess hormones. Mass effect symptoms are due to the tumor’s size and/or location. These are vision loss (particularly peripheral vision loss due to compression of the optic chiasm), headaches, fatigue, nausea, or vomiting. Hormonal symptoms include Cushing’s disease (from ACTH-producing tumors) which can lead to weight gain, facial roundness, and skin thinning. GH-producing tumors can cause acromegaly which leads to enlargement of hands/feet and coarse facial structures. Prolactin-producing tumors, prolactinomas, can cause menstrual irregularities, infertility, or galactorrhea. Hypopituitarism can cause fatigue, low libido, cold intolerance, or weight gain.

Why Size and Location Matter

The pituitary gland is located in a small bone cavity called the sella turcica which lies directly below the optic nerves and adjacent to critical blood vessels. Tumor growth could extend upward (suprasellar extension) or laterally into the cavernous sinus which could increase risks. Tumors greater than 1 cm often compress the optic chiasm and can lead to vision loss. Additionally, large or invasive tumors can affect multiple pituitary functions or extend into surrounding structures which can make complete surgical removal more challenging. If your tumor is small and asymptomatic, it may be recommended to continue observing the tumor site. However, with larger tumors or those causing symptoms, surgery is typically recommended.

Diagnosis and Evaluation

A brain MRI with pituitary protocol is the gold standard imaging technique to visualize the size and extension of the tumor. A comprehensive hormonal panel (blood work) is completed to assess for hormone excess or deficiency. And, formal visual field testing (perimetry) is performed if there is concern for potential optic nerve compression.

Treatment Options

  1. Observation utilizes routine MRIs and hormone testing every 6-12 months to monitor the tumor site. This treatment plan is a potential option for some non-functioning, asymptomatic macroadenomas if they are not growing.
  2. Medical therapy is primarily recommended for prolactin-producing tumors. In medical therapy, dopamine agonists such as cabergoline are administered to shrink tumors and normalize hormone levels without requiring surgical intervention.
  3. Endoscopic endonasal surgery is recommended for symptomatic non-prolactin-secreting macroadenomas. Instead of using an external incision site, an endoscope through the nose is used to remove the tumor while limiting damage to nearby brain and vascular structures.
  4. Radiosurgery (radiation therapy) is primarily recommended to treat residual tumors that surgical intervention could not remove, or inoperable tumors particularly those that extend into the cavernous sinus.

Surgical Risks and Outcomes

Endoscopic transsphenoidal surgery is typically safely tolerated by patients, especially with experienced surgeons. Risks include the following:

Cerebrospinal fluid (CSF) leak occurs in around 2-5% of cases. Infection such as meningitis or sinusitis occurs in less than 3% of cases. Hormonal imbalance (new hypopituitarism) occurs in around 10-20% of patients. This potential side effect may be temporary or permanent. If the optic nerve is impacted by treatment plans or the tumor itself, visual deterioration occurs in less than 1-2% of patients. Either temporary or permanent diabetes insipidus occurs in around 5-10% of cases.

Gross total resection success rates vary from around 70-90% depending on tumor size, location, and invasiveness. Surgical intervention can result in hormonal normalization for functioning tumors, especially for ACTH and GH-secreting adenomas.

Your Personalized Plan

After reviewing your MRI, hormone levels, and visual test, Dr. Yim will help determine the best treatment plan for you. His goal is to maximize safety while working to relieve pressure on the brain and optic nerves, restore your hormonal balance if possible, and minimize surgical risk.

When Is Surgery Recommended for a Pituitary Macroadenoma?

A recommendation for transsphenoidal surgery depends on tumor size, its location, hormonal activity, and experienced symptoms. The surgery itself involves a minimally invasive approach through the nose and sphenoid sinus.

Common indications surgical treatment may be needed are explained below:

  1. Vision changes or optic nerve compression

    



    Macroadenomas that extend upwards (i.e. suprasellar extension) can compress the optic chiasm. As a result, patients may experience a loss of peripheral vision (i.e. bitemporal hemaianopsia), blurry vision, reduced visual acuity, or rarely, double vision. In these cases, surgery may be needed urgently or semi-urgently when visual field testing confirms vision deficits and/or an MRI demonstrates optic chiasm compression. Surgery is performed to preserve or improve vision by decompressing the optic nerves. For many patients, visual symptoms improve within days or weeks after surgery.

    2. 


  2. Functioning (hormone-secreting) macroadenomas

    



    If the tumor is producing excess hormones, and medical therapy is insufficient, surgery may be recommended. Cushing’s disease (ACTH-producing tumor) secretes excess cortisol,leading to possible weight gain, diabetes, hypertension, and/or muscle weakness. Standard first treatment for this specific macroadenoma is surgical resection which yields a high potential for hormonal normalization. Acromegaly (GH-producing tumors) causes enlargement of hands/feet/organs and coarse facial features. Surgery is typically the recommended first treatment plan. TSH-producing tumors are rare but when present, lead to hyperthyroidism. They usually require surgical resection. Surgery is only recommended to treat prolactinomas when tumors are medication-resistant or intolerant. Otherwise, they are treated with dopamine agonists such as cabergoline.

    3. 


  3. Tumor growth or large size (both asymptomatic and symptomatic)

    


    If follow up MRIs demonstrate significant tumor growth, tumor size is larger than 2 cm (especially if close to the optic nerves or invading adjacent sites), or tumor causes pituitary gland compression, then surgery is often recommended as a preventative measure. Tumor removal would help avoid later issues such as vision loss or pituitary apoplexy.

    4. 


  4. Pituitary apoplexy

    



    Pituitary apoplexies require emergent attention. They occur when a sudden hemorrhage or infarction within the tumor is present. Pituitary apoplexies can cause sudden or severe headaches, acute vision loss, eye movement changes due to cranial nerve compression, altered consciousness. Transsphenoidal decompression is required urgently to relieve pressure.

    5. 


  5. Progressive hypopituitarism

    



    Surgery may be recommended if symptoms are progressive or are not controllable with medical therapy in order to decompress surrounding tissue. Additionally, if tumor growth risks worsening pituitary function, you may receive a surgery recommendation. Symptoms you may experience from progressive hypopituitarism are fatigue, low libido, infertility, low blood pressure, and general hypothyroidism symptoms.

Why Transsphenoidal Approach?

The transsphenoidal approach is used because it is minimally invasive and therefore, does not require external incision sites. As a result, this approach requires a shorter recovery time and lower complication rates than an open craniotomy would. It also provides direct access to the tumor through the nasal cavity and sphenoid sinus. The transsphenoidal approach is effective for most macroadenoma removals unless significant lateral or suprasellar extension.

How Pituitary Surgery Is Performed: Step-by-Step Overview of the Transsphenoidal Approach

To surgically remove pituitary macroadenomas, Dr. Yim typically uses a minimally invasive endoscopic transphenoidal approach through your nasal passage with high-definition endoscopes. No external incisions are made.

First, the patient will be placed under general anesthesia with the head slightly extended to provide a straight path to the base of the skull. After initial placing, a small endoscopic camera will be inserted into one nostril. The nasal passage is gently widened to allow room for visualization. Dr. Yim typically works between the nasal septum and middle turbinate to reach the back of the patient’s nose.




Step 3: Opening the Sphenoid Sinus

  • At the very back of the nasal cavity lies the sphenoid sinus, a hollow air space just in front of the pituitary gland.
    • 

  • A small opening is made in the sphenoid sinus wall, and the sinus cavity is carefully entered.
    • 

  • The back wall of the sphenoid sinus—called the sellar floor—is exposed.

Step 4: Exposing the Pituitary Gland

  • The sellar floor (bone overlying the pituitary gland) is thinned and carefully removed.
    • 

  • The dura mater (the membrane surrounding the pituitary gland) is opened.
    • 

  • The tumor is now visible under direct endoscopic guidance.

Step 5: Tumor Resection

  • Using specialized instruments, Dr. Yim carefully removes the pituitary tumor piece by piece.
    • 

  • The goal is to remove as much of the tumor as safely possible while preserving normal pituitary function and surrounding structures (optic nerves, carotid arteries).
    • 

  • In some cases, if the tumor invades adjacent spaces (e.g., cavernous sinus), complete resection may not be possible, and follow-up radiation may be considered.

Step 6: Reconstruction and Closure

  • Once the tumor is removed, the sella is reconstructed to prevent cerebrospinal fluid (CSF) leakage.
    • 

  • This may involve placing a fat graft, synthetic material, or nasal mucosal flap (vascularized tissue from inside the nose).
    • 

  • Surgical glue or packing may be used to hold the repair in place.

Step 7: Postoperative Care and Recovery

  • The patient is monitored in recovery, often in a neuro step-down or ICU setting overnight.
    • 

  • Most patients are discharged within 1–2 days.
    • 

  • Follow-up includes MRI imaging, hormone level checks, and endocrinology consultation.
    • 

  • Nasal congestion or mild drainage is expected, but patients are usually breathing through their nose again within days.

Summary: Why This Approach Is Preferred

Advantages of Transsphenoidal Surgery

No external incisions

Shorter recovery time than open surgery

Direct access to the pituitary gland

Lower risk of complications

Excellent outcomes for most macroadenomas

Interested in learning more about our practice?

Request Consultation
Scroll to Top